FDA 483 - Peyman Saadat MD, Inc. - February 20, 2024
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Peyman Saadat MD, Inc., a Reproductive Fertility Center in West Hollywood, CA, identified two significant observations. The firm made Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps) available for distribution before completing donor eligibility determinations. Additionally, the firm's HCT/P records lacked the required statement confirming communicable disease testing was performed by a CLIA-certified laboratory or one meeting equivalent CMS requirements.
ID · edbaeade-82ab-48bf-99c3-0a9a392832fa